• Find a fund

    Fund type

    Asset class

    Product range

  • Insights and researchEvents and webinarsEvents and webinarsEvents and webinarsIndex exposure analysis""

    Markets and economic outlook

  • Our servicesDiscover Vanguard 365""Client Connect: The Vanguard Advice Survey""
  • About VanguardAbout VanguardOur team""Fraud prevention""

    Corporate reports

    • FTSE 100 UCITS ETF - (GBP) Accumulating (VUKG)

    Available in other share classes
    Related Documents
    NAV Price ()
    —
    Market value ()
    —
    —
    Number of stocks
    —

    About this fund

    Fund objectives

    • The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE 100 Index (the “Index”).
    • The Index is comprised of large-sized company stocks in the UK.
    • The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.

    Fund facts

    Share class inception
    14 May 2019
    Listing date
    16 May 2019
    Investment structure
    Irish UCITS
    Share Class Assets'
    Total Assets
    Risk indicator
    Strategy
    Index
    Asset Class
    Equity
    Investment method
    Physical
    Index ticker
    UKXNUK
    Benchmark
    FTSE 100 Index
    Dividend schedule
    —
    Domicile
    Ireland
    Legal entity
    Vanguard Funds PLC
    Register countries
    Germany, Portugal, Ireland, Netherlands, Italy, Sweden, Switzerland, United Kingdom, Belgium, Luxembourg, Mexico, Norway, Finland, Austria, Spain, France, Liechtenstein and Denmark

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Performance

    Risk and Volatility

    As at 31 Mar 2026

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 102 99 31 Mar 2026
    Median market capital 66.2 B 66.2 B 31 Mar 2026
    16.3 x 16.2 x 31 Mar 2026
    2.2 x 2.2 x 31 Mar 2026
    13.0% 12.3% 31 Mar 2026
    17.9% 17.3% 31 Mar 2026
    Portfolio turnover rate -11.2% — 31 Mar 2026

    Market allocation

    As at 31 Mar 2026

    CountryRegionFundBenchmarkVariance +/-
    United KingdomEurope 99.79% 100.00% -0.21%
    Guernsey, C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I.Europe 0.21% 0.00% 0.21%

    Holdings details

    As at 31 Mar 2026

    Holding name% of market valueSectorRegionMarket valueShares
    AstraZeneca PLC 8.94767% Health Care GB £597,363,267.80 4,066,462
    HSBC Holdings PLC 8.52392% Financials GB £569,072,953.68 46,584,230
    Shell PLC 8.28597% Energy GB £553,186,715.15 15,439,205
    Rolls-Royce Holdings PLC 3.90122% Industrials GB £260,452,722.12 23,008,191
    BP PLC 3.86312% Energy GB £257,909,052.03 42,538,191
    British American Tobacco PLC 3.73880% Consumer Staples GB £249,609,320.67 5,710,577
    Unilever PLC 3.65986% Consumer Staples GB £244,338,886.22 5,818,978
    GSK PLC 3.35142% Health Care GB £223,746,949.92 10,840,453
    Rio Tinto PLC 2.91745% Basic Materials GB £194,774,339.20 2,804,930
    BAE Systems PLC 2.68777% Industrials GB £179,440,294.00 8,156,377

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or derivative instruments.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (GBP)
    £55.07
    Change
    -£0.41-0.75%
    At closure 24 Apr 2026
    Market value (EUR)
    €63.63
    Change
    -€0.48-0.75%
    At closure 24 Apr 2026
    NAV 52-week high
    £57.41
    At closure 27 Apr 2026
    Market value 52-week high
    €65.69
    At closure 27 Apr 2026
    NAV 52-week low
    £43.27
    At closure 27 Apr 2026
    Market value 52-week low
    €51.08
    At closure 27 Apr 2026
    NAV 52-week difference
    £14.14
    Change
    +24.63%
    At closure 27 Apr 2026
    Market value 52-week difference
    €14.61
    Change
    +22.24%
    At closure 27 Apr 2026
    Outstanding shares
    45,494,944
    At closure 31 Mar 2026
    Historical Prices

    -

    Inception date

    14 May 2019

    Listing date

    09 Mar 2023

    Date NAV (GBP) Market price (EUR)
    24 Apr 2026 £55.0724 €63.6300
    23 Apr 2026 £55.4858 €64.1100
    22 Apr 2026 £55.5383 €64.0900
    21 Apr 2026 £55.6523 €64.0500
    20 Apr 2026 £56.2414 €64.7200
    17 Apr 2026 £56.5494 €65.0900
    16 Apr 2026 £56.1396 €64.6300
    15 Apr 2026 £55.9553 €64.5100
    14 Apr 2026 £56.2146 €64.8500
    13 Apr 2026 £56.0792 €64.6000

    Distribution history

    Distribution frequency

    —

    Historical performance 31 Mar 2026

    3.01%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currencies and stock exchanges

    Listed currencies: EUR, GBP, MXN

    Base currency: GBP

    Exchanges: Deutsche Boerse, London Stock Exchange, Bolsa Mexicana De Valores

    Fund codes

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.